Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Hurricane Lee Expected to Grow As It Turns North
Hurricane Lee, still a Category 3 storm with winds of 115 mph, is expected to increase in size but be significantly weaker in the coming days, as it turns north to reach the U.S. East Coast, according to the National Hurricane Center.
Load More